Good Samaritan Regional Medical Center is a 188-bed teaching hospital located in Corvallis, Oregon, United States. Founded in 1922, it is the only hospital in the city. The hospital operates a level II trauma center, and serves the Linn, Benton, and Lincoln County area.

There are 188 beds in Good Samaritan Hospital.

During the past decade, Good Samaritan Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 10 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Good Samaritan Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Good Samaritan Regional Medical Center, Oregon" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Good Samaritan Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Good Samaritan Hospital" are "Breast Cancer" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Recurrent Lung Non-Small Cell Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Good Samaritan Hospital" in a lesser frequency.

Most popular intervention types in "Good Samaritan Hospital" are "Drug" (32 trials), "Other" (20 trials), "Biological" (9 trials), "Procedure" (8 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Quality-of-Life Assessment" (8 trials), "Biospecimen Collection" (6 trials), "Carboplatin" (6 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Good Samaritan Hospital" are 40 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Good Samaritan Hospital". undefined are not yet recruiting, 15 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Good Samaritan Hospital, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Good Samaritan Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".

Good Samaritan Hospital has several departments that took part in Clinical trials: "Samaritan Regional Cancer Center" - 7 trials, "Samaritan Heart & Vascular Institute - Cardiology Dept." - 5 trials, "Samaritan Heart & Vascular Institute" - 2 trials, "Samaritan Hematology & Oncology Consultants" - 2 trials